“(It) has the capacity to make the very early diagnosis of melanoma.” He said the test, called Melaseq, could detect changes ...

Microbiotica has dosed the first subject in the Phase Ib MELODY-1 clinical trial of MB097, a precision microbiome co-therapy ...

CAMBRIDGE, United Kingdom, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic ...